April 3, 2015 : Episode 1

Abiraterone Label Expanded, Phase III Melanoma Data, SGR Repeal, and More


Related Videos
Kara N. Maxwell, MD, PhD
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Rohan Garje, MD
Jeffrey P. Townsend, PhD
Rohan Garje, MD
Josep Maria Piulats Rodriguez, MD, PhD
Angela Jia, MD, PhD, of University Hospitals
Rohan Garje, MD, chief, Genitourinary Medical Oncology, Baptist Health Miami Cancer Institute
Zeynep Eroglu, MD
Zeynep Eroglu, MD